-
Mashup Score: 18
“How often do you receive financial support from parents or other relatives?” To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.Login […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
If the FDA Oncology Center of Excellence (OCE) began an “innovation challenge” in oncology drug development, what would that look like? To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The Biden administration has—for the second time—delayed the decision on a proposed FDA rule that would ban menthol cigarettes and all flavors in cigars. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The FY24 Defense Appropriations Act provides funding for the Rare Cancers Research Program to support research of exceptional scientific merit in the area of rare cancers research. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Enhertu improves PFS in HR-positive, HER2-low breast cancer in phase III trial - The Cancer Letter - 3 day(s) ago
Positive high-level results from the DESTINY-Breast06 phase III trial showed that Enhertu (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared to standard-of-care chemotherapy in the primary trial population of patients with HR-positive, HER2-low (IHC 1+ or 2+/ISH-) metastatic breast cancer following one or more lines of endocrine therapy. To […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump - The Cancer Letter - 3 day(s) ago
Over the past three years, the American Cancer Society has recovered from the fundraising decline brought on by COVID-19 and has reversed the years-long fundraising slump in public support. This three-year financial performance has led the charity’s board to extend the employment contract for its CEO, Karen E. Knudsen. Public support for the charity has […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0MD Anderson and PAHO collaborate to support cancer prevention, control in Americas - The Cancer Letter - 3 day(s) ago
MD Anderson Cancer Center and the Pan American Health Organization are collaborating to strengthen cancer prevention and control initiatives across the Americas. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Keytruda combination improves OS for HER2-positive advanced gastric cancer in phase III trial - The Cancer Letter - 4 day(s) ago
The phase III KEYNOTE-811 trial evaluating Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with trastuzumab and fluoropyrimidine- and platinum-containing chemotherapy met its dual primary endpoint of overall survival for the first-line treatment of patients with human epidermal growth factor receptor 2-positive locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. To access this subscriber-only […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump - The Cancer Letter - 4 day(s) ago
Over the past three years, the American Cancer Society has recovered from the fundraising decline brought on by COVID-19 and has reversed the years-long fundraising slump in public support. This three-year financial performance has led the charity’s board to extend the employment contract for its CEO, Karen E. Knudsen. Public support for the charity has […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The Biden administration has—for the second time—delayed the decision on a proposed FDA rule that would ban menthol cigarettes and all flavors in cigars. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log […]
Source: cancerletter.comCategories: General Medicine News, Onc News and JournalsTweet
Voices of Black women can improve cancer outcomes. Guest editorial by @AmericanCancer's @AlpaVPatel. #HealthEquity https://t.co/5bcK0zoQ4l